# Rejuveron Life Sciences AG — Form D

Rejuveron Life Sciences AG of SCHLIEREN, V8, a company, filed a Form D exempt-offering notice with the SEC on 2021-03-26. The offering totals $16.9M, of which $1.3M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2021-03-26
- Form: D
- Accession: 0001849162-21-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $16.9M
- Amount sold: $1.3M
- Remaining: $15.6M
- Minimum investment: $100K
- Investors: 4
- Date of first sale: 2020-12-09
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-393598

## Issuer

- Name: Rejuveron Life Sciences AG
- CIK: 0001849162
- Entity type: Corporation
- Jurisdiction: SWITZERLAND
- Incorporated: 2019
- Address: WAGISTRASSE 18 8952, SCHLIEREN, V8, 00000
- Phone: 0041 78 689 3024

## Officers, directors & promoters (2)

| Name | Role | Location |
| --- | --- | --- |
| GAETAN IRRMANN | Executive Officer | PARIS, I0 |
| PIERRE-ANTOINE MUDRY | Executive Officer | SCHLIEREN, V8 |

## More

- [CIK 1849162 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1849162&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001849162-21-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.